Aims: The objective of the present study was to explore the comorbidity of borderline personality disorder (BPD) with other personality disorders in adolescents and compare these comorbidities in male and female subjects. Methods: The sample was drawn from a European research project investigating the phenomenology of BPD in adolescence (EURNET BPD). A total of 85 BPD patients (11 boys and 74 girls) with a mean age of 16.3 years were included in the study. Results: According to the results of the Structured Interview for DSM-IV Disorders of Personality, obsessive-compulsive (35.3%), antisocial (22.4%), avoidant (21.2%), dependent (11.8%) and paranoid (9.4%) personality disorders had significant co-occurrences with BPD. Although none of the gender differences was statistically significant, we observed a trend towards higher rates of antisocial personality disorders in men (45.5%) than in women (19%). Conclusion: The study results confirmed the frequency of Axis II comorbidity in adolescents with BPD and, for the first time, evidenced a differential pattern of comorbidity in males and females. This differential pattern must be taken into account when developing treatment strategies for adolescents with BPD.

Keywords:
Adolescents, Borderline personality disorder, Personality disorders, Comorbidity
1.
Miller AL, Muehlenkamp JJ, Jacobson CM: Fact or fiction: diagnosing borderline personality disorder in adolescents. Clin Psychol Rev 2008;28:969-981.
2.
Becker DF, Grilo CM, Edell WS, Mc Glashan TH: Comorbidity of borderline personality disorder with other personality disorders in hospitalized adolescents and adults. Am J Psychiatry 2000;157:2011-2016.
3.
Chabrol H, Chouicha K, Montovany A, Callahan S, Duconge E, Sztulman H: Personality disorders in a nonclinical sample of adolescents (in French). Encephale 2002;28:520-524.
4.
Chanen AM, Jovev M, Jackson HJ: Adaptive functioning and psychiatric symptoms in adolescents with borderline personality disorder. J Clin Psychiatry 2007;68:297-306.
5.
Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR: Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry 2006;163:827-832.
6.
McCormick B, Blum N, Hansel R, Franklin JA, St John D, Pfohl B, Allen J, Black DW: Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder. Compr Psychiatry 2007;48:406-412.
7.
Tadić A, Wagner S, Hoch J, Başkaya O, von Cube R, Skaletz C, Lieb K, Dahmen N: Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder. Psychopathology 2009;42:257-263.
8.
Barrachina J, Pascual JC, Ferrer M, Soler J, Rufat MJ, Andión O, Tiana T, Martín-Blanco A, Casas M, Pérez V: Axis II comorbidity in borderline personality disorder is influenced by sex, age, and clinical severity. Compr Psychiatry 2011;52:725-730.
9.
Corcos M, Pham-Scottez A, Speranza M: European Research Network on Borderline Personality Disorder (EURNET-BPD). 57th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. New research poster session N° 312. New York: 28-31 October 2010.
10.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4.Washington, American Psychiatric Association, 1994.
11.
Pfohl B, Blum N, Zimmerman M: Structured Interview for DSM-IV Personality. Washington, American Psychiatric Press, 1997.
12.
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997;36:980-988.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.